Literature DB >> 12006796

Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients.

Klaus Tschaikowsky1, Monika Hedwig-Geissing, Albert Schiele, Frank Bremer, Michael Schywalsky, Jürgen Schüttler.   

Abstract

OBJECTIVE: To determine the time course of histocompatibility leukocyte antigen (HLA)-DR expression in peripheral blood mononuclear cells and their relationship to markers of inflammation, organ function, and outcome during severe sepsis.
DESIGN: Prospective, longitudinal study.
SETTING: University hospital intensive care unit. PATIENTS: Twenty-three postoperative patients with severe sepsis and 26 patients with uneventful postoperative course as well as 24 healthy, age-matched subjects.
INTERVENTIONS: Serum procalcitonin was determined by using an immunochemiluminescence assay, and C-reactive protein and leukocyte antigens were determined by using flow cytometry over 14 days in parallel with clinical data collection.
MEASUREMENTS AND MAIN RESULTS: Despite a relative lymphopenia, absolute lymphocyte counts and CD4+/CD8+ T-cell ratio in septic patients were significantly elevated above normal. Particularly, CD4+ and CD8+ T-cell counts in nonsurvivors of sepsis were approximately twice as high as those of survivors. Significantly decreased monocytic HLA-DR expression was observed in both survivors and nonsurvivors at the onset of severe sepsis. Percentages of HLA-DR+ lymphocytes, however, were significantly increased during sepsis, especially in nonsurvivors. Whereas survivors of sepsis showed a continuous recovery of monocytic HLA-DR expression to >or=70% within 10 days, nonsurvivors were characterized by a second decrease in monocytic HLA-DR expression after day 7 or a permanent suppression (<40%). Peak of systemic inflammatory reaction, documented by maximum serum concentrations of procalcitonin and C-reactive protein, coincided with the nadir of monocytic HLA-DR expression. Moreover, procalcitonin and C-reactive protein as well as scores on the Acute Physiology and Chronic Health Evaluation II and Sepsis Organ Failure Assessment were inversely correlated with the monocytic HLA-DR expression.
CONCLUSIONS: Decreases in monocytic HLA-DR expression occurred simultaneously with signs of hyperinflammation as early as the onset of severe sepsis and usually developed in opposite directions than inflammatory markers and sepsis severity scores.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006796     DOI: 10.1097/00003246-200205000-00010

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  43 in total

1.  Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis.

Authors:  Philip A Berry; Charalambos G Antoniades; Ivana Carey; Mark J W McPhail; Munther J Hussain; Edward T Davies; Julia A Wendon; Diego Vergani
Journal:  Intensive Care Med       Date:  2010-12-16       Impact factor: 17.440

2.  Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response.

Authors:  Sarah Newton; Yanli Ding; Chun-Shiang Chung; Yaping Chen; Joanne L Lomas-Neira; Alfred Ayala
Journal:  Surg Infect (Larchmt)       Date:  2004       Impact factor: 2.150

3.  Immunonutrition in the critically ill: from old approaches to new paradigms.

Authors:  Daren Heyland; Rupinder Dhaliwal
Journal:  Intensive Care Med       Date:  2005-03-08       Impact factor: 17.440

4.  Intensive versus conventional insulin therapy in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial.

Authors:  Shou-Gen Cao; Jian-An Ren; Bo Shen; Dong Chen; Yan-Bing Zhou; Jie-Shou Li
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

Review 5.  Spontaneous bacterial peritonitis: from pathophysiology to prevention.

Authors:  Mauro Bernardi
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

6.  Chronic sepsis mortality characterized by an individualized inflammatory response.

Authors:  Marcin F Osuchowski; Kathy Welch; Huan Yang; Javed Siddiqui; Daniel G Remick
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

7.  Immune status in sepsis: the bug, the site of infection and the severity can make the difference.

Authors:  Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  Crit Care       Date:  2010-06-18       Impact factor: 9.097

8.  Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis.

Authors:  Marcin F Osuchowski; Florin Craciun; Katrin M Weixelbaumer; Elizabeth R Duffy; Daniel G Remick
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

Review 9.  Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.

Authors:  Guillaume Monneret; Fabienne Venet; Alexandre Pachot; Alain Lepape
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

10.  Epidermal wound healing in severe sepsis and septic shock in humans.

Authors:  Marjo Koskela; Fiia Gäddnäs; Tero I Ala-Kokko; Jouko J Laurila; Juha Saarnio; Aarne Oikarinen; Vesa Koivukangas
Journal:  Crit Care       Date:  2009-06-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.